List of Tables

Table 1. Cetuximab Biosimilar Consumption Value & CAGR: China VS Global, 2020-2031, US$ Million

Table 2. Cetuximab Biosimilar Market Restraints

Table 3. Cetuximab Biosimilar Market Trends

Table 4. Cetuximab Biosimilar Industry Policy

Table 5. Global Cetuximab Biosimilar Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 6. Global Cetuximab Biosimilar Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 7. Global Cetuximab Biosimilar Sales Quantity by Company, (2020-2025) & (K Pcs), Ranked Based on Sales in 2024

Table 8. Global Cetuximab Biosimilar Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 9. Global Cetuximab Biosimilar Average Selling Price (ASP) by Company, (2020-2025) & (US$/Pcs)

Table 10. Global Cetuximab Biosimilar Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Cetuximab Biosimilar Mergers & Acquisitions, Expansion Plans

Table 12. Global Cetuximab Biosimilar Manufacturers Product Type

Table 13. Head Office and Cetuximab Biosimilar Production Site of Key Manufacturer

Table 14. Cetuximab Biosimilar Capacity of Major Manufacturers and Future Plan

Table 15. China Cetuximab Biosimilar Revenue by Company, 2020-2025, US$ million, Ranked Based on Revenue in 2024

Table 16. China Cetuximab Biosimilar Revenue Share by Company, 2020-2025, Ranked by Data of 2024

Table 17. China Cetuximab Biosimilar Sales Quantity by Company, (2020-2025) & (K Pcs), Ranked Based on Sales in 2024

Table 18. China Cetuximab Biosimilar Sales Quantity by Company, 2020-2025, Ranked by Data of 2024

Table 19. Global Cetuximab Biosimilar Production & Forecast by Region, 2020 VS 2024 VS 2031, (K Pcs)

Table 20. Global Cetuximab Biosimilar Production by Region, 2020-2025, (K Pcs)

Table 21. Global Cetuximab Biosimilar Production Forecast by Region, 2026-2031, (K Pcs)

Table 22. Global Key Players of Cetuximab Biosimilar Upstream (Raw Materials)

Table 23. Global Cetuximab Biosimilar Typical Customers

Table 24. Cetuximab Biosimilar Typical Distributors

Table 25. by Type, Global Cetuximab Biosimilar Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 26. by Application, Global Cetuximab Biosimilar Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 27. By Region, Global Cetuximab Biosimilar Consumption Value, 2020 VS 2024 VS 2031, US$ Million

Table 28. By Region, Global Cetuximab Biosimilar Consumption Value, 2020-2031, US$ Million

Table 29. By Region, Global Cetuximab Biosimilar Sales Quantity, 2020-2031, (K Pcs)

Table 30. By Country, Global Cetuximab Biosimilar Consumption Value & CAGR, 2020 VS 2024 VS 2031, US$ Million

Table 31. By Country, Global Cetuximab Biosimilar Consumption Value, 2020-2031, US$ Million

Table 32. By Country, Global Cetuximab Biosimilar Consumption Value Market Share, 2020-2031

Table 33. By Country, Global Cetuximab Biosimilar Sales Quantity, 2020-2031, (K Pcs)

Table 34. By Country, Global Cetuximab Biosimilar Sales Quantity Market Share, 2020-2031

Table 35. Actavis Company Information, Head Office, Market Area, and Industry Position

Table 36. Actavis Cetuximab Biosimilar Models, Specifications, and Application

Table 37. Actavis Cetuximab Biosimilar Sales Quantity (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin, 2020-2025

Table 38. Actavis Company Profile and Main Business

Table 39. Actavis Recent Developments

Table 40. Amgen Company Information, Head Office, Market Area, and Industry Position

Table 41. Amgen Cetuximab Biosimilar Models, Specifications, and Application

Table 42. Amgen Cetuximab Biosimilar Sales Quantity (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin, 2020-2025

Table 43. Amgen Company Profile and Main Business

Table 44. Amgen Recent Developments

Table 45. Celltrion Company Information, Head Office, Market Area, and Industry Position

Table 46. Celltrion Cetuximab Biosimilar Models, Specifications, and Application

Table 47. Celltrion Cetuximab Biosimilar Sales Quantity (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin, 2020-2025

Table 48. Celltrion Company Profile and Main Business

Table 49. Celltrion Recent Developments

Table 50. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 51. Pfizer Cetuximab Biosimilar Models, Specifications, and Application

Table 52. Pfizer Cetuximab Biosimilar Sales Quantity (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin, 2020-2025

Table 53. Pfizer Company Profile and Main Business

Table 54. Pfizer Recent Developments

Table 55. Bio X Cell Company Information, Head Office, Market Area, and Industry Position

Table 56. Bio X Cell Cetuximab Biosimilar Models, Specifications, and Application

Table 57. Bio X Cell Cetuximab Biosimilar Sales Quantity (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin, 2020-2025

Table 58. Bio X Cell Company Profile and Main Business

Table 59. Bio X Cell Recent Developments

Table 60. Wuhan Dima Biotechnology Company Information, Head Office, Market Area, and Industry Position

Table 61. Wuhan Dima Biotechnology Cetuximab Biosimilar Models, Specifications, and Application

Table 62. Wuhan Dima Biotechnology Cetuximab Biosimilar Sales Quantity (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin, 2020-2025

Table 63. Wuhan Dima Biotechnology Company Profile and Main Business

Table 64. Wuhan Dima Biotechnology Recent Developments

Table 65. Guangdong ANNPO Biotechnology Company Information, Head Office, Market Area, and Industry Position

Table 66. Guangdong ANNPO Biotechnology Cetuximab Biosimilar Models, Specifications, and Application

Table 67. Guangdong ANNPO Biotechnology Cetuximab Biosimilar Sales Quantity (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin, 2020-2025

Table 68. Guangdong ANNPO Biotechnology Company Profile and Main Business

Table 69. Guangdong ANNPO Biotechnology Recent Developments

List of Figures

Figure 1. Cetuximab Biosimilar Picture

Figure 2. Global Cetuximab Biosimilar Consumption Value, (US$ million) & (2020-2031)

Figure 3. Global Cetuximab Biosimilar Sales Quantity, (K Pcs) & (2020-2031)

Figure 4. Global Cetuximab Biosimilar Average Selling Price (ASP), (2020-2031) & (US$/Pcs)

Figure 5. China Cetuximab Biosimilar Consumption Value, (US$ million) & (2020-2031)

Figure 6. China Cetuximab Biosimilar Sales Quantity (K Pcs) & (2020-2031)

Figure 7. China Cetuximab Biosimilar Average Selling Price (ASP), (US$/Pcs) & (2020-2031)

Figure 8. By Consumption Value, China Cetuximab Biosimilar Market Share of Global, 2020-2031

Figure 9. By Sales Quantity, China Cetuximab Biosimilar Market Share of Global, 2020-2031

Figure 10. Global Cetuximab Biosimilar Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2024

Figure 11. China Cetuximab Biosimilar Key Participants, Market Share, 2024

Figure 12. Global Cetuximab Biosimilar Capacity, Production and Capacity Utilization, 2020-2031

Figure 13. Global Cetuximab Biosimilar Capacity Market Share by Region, 2024 VS 2031

Figure 14. Global Cetuximab Biosimilar Production Market Share & Forecast by Region, 2020-2031

Figure 15. Cetuximab Biosimilar Industry Chain

Figure 16. Cetuximab Biosimilar Procurement Model

Figure 17. Cetuximab Biosimilar Sales Model

Figure 18. Cetuximab Biosimilar Sales Channels, Direct Sales, and Distribution

Figure 19. 100 mg/50 mL Injection

Figure 20. 200 mg/100 mL Injection

Figure 21. by Type, Global Cetuximab Biosimilar Consumption Value, 2020-2031, US$ Million

Figure 22. by Type, Global Cetuximab Biosimilar Consumption Value Market Share, 2020-2031

Figure 23. by Type, Global Cetuximab Biosimilar Sales Quantity, 2020-2031, (K Pcs)

Figure 24. by Type, Global Cetuximab Biosimilar Sales Quantity Market Share, 2020-2031

Figure 25. by Type, Global Cetuximab Biosimilar Average Selling Price (ASP), 2020-2031, (US$/Pcs)

Figure 26. Metastatic colorectal cancer

Figure 27. Metastatic breast cancer

Figure 28. Non-small cell lung cancer

Figure 29. Other

Figure 30. by Application, Global Cetuximab Biosimilar Consumption Value, 2020-2031, US$ Million

Figure 31. by Application, Global Cetuximab Biosimilar Revenue Market Share, 2020-2031

Figure 32. by Application, Global Cetuximab Biosimilar Sales Quantity, 2020-2031, (K Pcs)

Figure 33. by Application, Global Cetuximab Biosimilar Sales Quantity Market Share, 2020-2031

Figure 34. by Application, Global Cetuximab Biosimilar Price, 2020-2031, (US$/Pcs)

Figure 35. By Region, Global Cetuximab Biosimilar Consumption Value Market Share, 2020-2031

Figure 36. By Region, Global Cetuximab Biosimilar Sales Quantity Market Share, 2020-2031

Figure 37. North America Cetuximab Biosimilar Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 38. By Country, North America Cetuximab Biosimilar Consumption Value Market Share, 2024

Figure 39. Europe Cetuximab Biosimilar Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 40. By Country, Europe Cetuximab Biosimilar Consumption Value Market Share, 2024

Figure 41. Asia Pacific Cetuximab Biosimilar Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 42. By Country/Region, Asia Pacific Cetuximab Biosimilar Consumption Value Market Share, 2024

Figure 43. South America Cetuximab Biosimilar Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 44. By Country, South America Cetuximab Biosimilar Consumption Value Market Share, 2024

Figure 45. Middle East & Africa Cetuximab Biosimilar Consumption Value & Forecasts, 2020-2031, US$ Million

Figure 46. United States Cetuximab Biosimilar Sales Quantity, 2020-2031, (K Pcs)

Figure 47. by Type, United States Cetuximab Biosimilar Sales Quantity Market Share, 2024 VS 2031

Figure 48. by Application, United States Cetuximab Biosimilar Sales Quantity Market Share, 2024 VS 2031

Figure 49. Europe Cetuximab Biosimilar Sales Quantity, 2020-2031, (K Pcs)

Figure 50. by Type, Europe Cetuximab Biosimilar Sales Quantity Market Share, 2024 VS 2031

Figure 51. by Application, Europe Cetuximab Biosimilar Sales Quantity Market Share, 2024 VS 2031

Figure 52. China Cetuximab Biosimilar Sales Quantity, 2020-2031, (K Pcs)

Figure 53. by Type, China Cetuximab Biosimilar Sales Quantity Market Share, 2024 VS 2031

Figure 54. by Application, China Cetuximab Biosimilar Sales Quantity Market Share, 2024 VS 2031

Figure 55. Japan Cetuximab Biosimilar Sales Quantity, 2020-2031, (K Pcs)

Figure 56. by Type, Japan Cetuximab Biosimilar Sales Quantity Market Share, 2024 VS 2031

Figure 57. by Application, Japan Cetuximab Biosimilar Sales Quantity Market Share, 2024 VS 2031

Figure 58. South Korea Cetuximab Biosimilar Sales Quantity, 2020-2031, (K Pcs)

Figure 59. by Type, South Korea Cetuximab Biosimilar Sales Quantity Market Share, 2024 VS 2031

Figure 60. by Application, South Korea Cetuximab Biosimilar Sales Quantity Market Share, 2024 VS 2031

Figure 61. Southeast Asia Cetuximab Biosimilar Sales Quantity, 2020-2031, (K Pcs)

Figure 62. by Type, Southeast Asia Cetuximab Biosimilar Sales Quantity Market Share, 2024 VS 2031

Figure 63. by Application, Southeast Asia Cetuximab Biosimilar Sales Quantity Market Share, 2024 VS 2031

Figure 64. India Cetuximab Biosimilar Sales Quantity, 2020-2031, (K Pcs)

Figure 65. by Type, India Cetuximab Biosimilar Sales Quantity Market Share, 2024 VS 2031

Figure 66. by Application, India Cetuximab Biosimilar Sales Quantity Market Share, 2024 VS 2031

Figure 67. Middle East & Africa Cetuximab Biosimilar Sales Quantity, 2020-2031, (K Pcs)

Figure 68. by Type, Middle East & Africa Cetuximab Biosimilar Sales Quantity Market Share, 2024 VS 2031

Figure 69. by Application, Middle East & Africa Cetuximab Biosimilar Sales Quantity Market Share, 2024 VS 2031

Figure 70. Research Methodology

Figure 71. Breakdown of Primary Interviews

Figure 72. Bottom-up Approaches

Figure 73. Top-down Approaches